Tagariello, G <br/><br/>
Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.  [electronic resource] 

 -  Haemophilia : the official journal of the World Federation of Hemophilia  Sep 2000 
 - 581-3 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1351-8216 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2516.2000.00400.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Arthroplasty, Replacement, Hip--adverse effects<br/>Blood Loss, Surgical--prevention & control<br/>Factor VIII--adverse effects<br/>Factor VIIa--administration & dosage<br/>Hemophilia A--complications<br/>Hemostasis--drug effects<br/>Humans<br/>Infusions, Parenteral<br/>Isoantibodies--blood<br/>Male<br/>Recombinant Proteins--administration & dosage<br/>Sodium Chloride--administration & dosage<br/>Tranexamic Acid--administration & dosage